Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Non-alcoholic fatty liver disease Stories

2014-04-14 12:30:21

A UK study investigating the link between low vitamin D status and non-alcoholic fatty liver disease (NAFLD) in British children has identified a genetic variant associated with the disease's severity. The research, conducted by the King's College Hospital Paediatric Liver Centre and the University of Surrey's School of Biosciences and Medicine, and funded by the Children's Liver Disease Foundation retrospectively analyzed the medical records of 120 pediatric patients with NAFLD. The...

2014-04-10 13:46:07

Two new studies presented today at the International Liver CongressTM 2014 have provided more evidence to clarify the role of non-alcoholic fatty liver disease (NAFLD) as an independent risk factor for the development of cardiovascular disease (CVD). In the first long-term study , in patients at high CVD risk, NAFLD was shown to contribute to the progression of early atherosclerosis independently of traditional CVD risk factors. In a second long-term study , NAFLD was confirmed as a...

2014-03-30 23:01:42

Frank R. Sinatra, MD, Professor of Pediatrics and Assistant Dean for Faculty Development, Keck School of Medicine, University of Southern California, Los Angeles, presented on Hepatitis C: Progress and Challenges, Nonalcoholic Fatty Liver Disease: Part of a Bigger Problem. Glendale, CA (PRWEB) March 30, 2014 Audio-Digest Foundation Announces the Release of Pediatrics Volume 60, Issue 02: Hepatitis C/Nonalcoholic Fatty Liver Disease. The goals of this program are to improve the management...

2014-03-22 23:03:03

ReportsnReports.com offers "OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update" 2014 market research report in its store. Dallas, TX (PRWEB) March 22, 2014 OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update report estimates the 2012 off-label sales for nonalcoholic steatohepatitis (NASH) to be approximately $233m across the US and five...

2014-03-11 08:29:53

Funding to support clinical development of treatments for rare cholestatic liver diseases and nonalcoholic steatohepatitis SAN DIEGO, March 11, 2014 /PRNewswire/ -- Lumena Pharmaceuticals (Lumena), a biopharmaceutical company focused on the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, today announced that it has secured $45 million in Series B financing. New Enterprise Associates (NEA) led the financing,...

2014-03-04 16:20:56

Metabolic profiling of liver cells suggests new treatments for cirrhosis patients In a new study that could help doctors extend the lives of patients awaiting liver transplants, a Rice University-led team of researchers examined the metabolic breakdown that takes place in liver cells during late-stage cirrhosis and found clues that suggest new treatments to delay liver failure. More than 17,000 Americans are awaiting a liver transplant, and of those, about 1,500 will die this year while...

2014-02-26 16:25:07

LONDON, Feb. 26, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:EpiCast Report: Nonalcoholic Steatohepatitis - Epidemiology Forecast to 2022EpiCast Report: Nonalcoholic Steatohepatitis - Epidemiology Forecast to 2022SummaryNonalcoholic steatohepatitis (NASH) is a common, often clinically silent liver disease characterized by the presence of a fatty, inflamed, and damaged liver. It resembles alcoholic liver disease, but occurs in people who drink...

2014-01-27 08:28:08

New Hope for Fatty Liver Disease Sufferers: BergaMet(TM) citrus bergamot extract now proven effective for patients with NAFLD DENVER, Jan. 27, 2014 /PRNewswire/ -- Two separate studies conducted in Italy reveal that a highly concentrated proprietary extract of the Calabrian bergamot fruit (38% citrus bergamot extract, BergaMet(TM)/NatHealthsolutions) powerfully benefits patients with nonalcoholic fatty liver disease (NAFLD). Previous research has shown BergaMet(TM) to be a powerful...

Coffee Boosts Blood Flow
2013-11-21 11:29:38

Brett Smith for redOrbit.com - Your Universe Online Based on personal experience, you may already know that coffee stimulates blood flow, but a new study from a team of Japanese researchers has found that caffeine found in coffee may only be part of the story. In a new study presented at the American Heart Association’s Scientific Sessions 2013 in Dallas this week, a cup of caffeinated coffee caused a 30 percent increase in blood flow over a 75-minute period. The study team noted...

2013-11-04 23:20:02

In-demand research report “OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017” elaborated by GlobalData has been recently published by Market Publishers Ltd. According to the study, the world NASH market is likely to grow at a 30% CAGR to surpass the USD 862.9 billion mark by 2017. London, UK (PRWEB) November 04, 2013 Currently, the nonalcoholic steatohepatitis (NASH) market environment is very sparse on the back of high levels of...